Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Value of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216 is registered in ClinicalTrials.gov with Man Hu as lead sponsor.

NCT NCT06690216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Value of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
Lead sponsor
Man Hu
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
March 30, 2024
Completion date
October 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, glioblastoma (gbm), head and neck squamous cell carcinoma, non-small cell lung cancer